1. Home
  2. QTRX vs BDSX Comparison

QTRX vs BDSX Comparison

Compare QTRX & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$3.87

Market Cap

160.0M

Sector

Industrials

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$21.82

Market Cap

153.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTRX
BDSX
Founded
2007
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Precision Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.0M
153.3M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
QTRX
BDSX
Price
$3.87
$21.82
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$6.00
$32.50
AVG Volume (30 Days)
1.1M
94.5K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,632,000.00
$88,499,000.00
Revenue This Year
$25.49
$25.26
Revenue Next Year
$10.04
$19.15
P/E Ratio
N/A
N/A
Revenue Growth
64.52
24.08
52 Week Low
$2.40
$0.29
52 Week High
$8.77
$24.92

Technical Indicators

Market Signals
Indicator
QTRX
BDSX
Relative Strength Index (RSI) 54.38 60.37
Support Level $2.98 $6.63
Resistance Level $4.57 $24.92
Average True Range (ATR) 0.37 2.38
MACD -0.02 -0.03
Stochastic Oscillator 51.80 63.67

Price Performance

Historical Comparison
QTRX
BDSX

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: